{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-031098","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2024-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.568484+00:00","generated_at":"2026-05-31T23:29:01.557467+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intensity Therapeutics enters $15M at-the-market equity offering with H.C. Wainwright","bullets":["Up to $15M of common stock may be sold from time to time via ATM sales agent.","Sales agent commission: 3.0% of gross proceeds; agreement dated July 3, 2024.","Offering made under shelf registration statement filed same day (333-280681).","Company has no obligation to sell; may suspend or terminate the Sales Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-031098","json":"https://secwatch.observer/filing/0001628280-24-031098.json","markdown":"https://secwatch.observer/filing/0001628280-24-031098.md","text":"https://secwatch.observer/filing/0001628280-24-031098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000162828024031098/0001628280-24-031098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000162828024031098/intensity-20240703.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:29:01.557467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}